glp-1 drugs and anesthesia medications safe to continue before surgery in patients with diabetes obesity GLP-1 Costs Explained: Managing Coverage

Specifically, the primary care data can be requested via application to the CPRD ().

Ozempic, Wegovy and Mounjaro accounted for nearly $4-billion in sales at retail pharmacies in 2025, according to IQVIA Canada

Gastric ultrasound identifies increased residual gastric contents in patients on GLP-1 receptor agonists, showing that shorter drug withholding and fasting times are linked to higher aspiration risk before anesthesia.

FDA Enforcement Actions and Safety Concerns In September 2025, the FDA issued over 50 warning letters to compounders marketing GLP-1 products as generic equivalents to FDA-approved drugs

Humana blocks Wegovy for weight loss using automated diagnosis code editsnot PA denials

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide and tirzepatide, have emerged as transformative agents for type 2 diabetes and obesity through their potent effects on weight reduction, insulin sensitivity, and cardiovascular outcomes